Malignant neoplasm of endometrium
ICD-10 C54.1 is a billable code used to indicate a diagnosis of malignant neoplasm of endometrium.
C54.1 refers to malignant neoplasms of the endometrium, which is the inner lining of the uterus. This condition is commonly known as endometrial cancer and is one of the most prevalent gynecologic malignancies. It typically arises from the glandular cells of the endometrium and is often associated with abnormal uterine bleeding, pelvic pain, and other symptoms. Risk factors include obesity, diabetes, hypertension, and prolonged exposure to estrogen without progesterone. Diagnosis is usually confirmed through endometrial biopsy, imaging studies, and sometimes hysteroscopy. The staging of endometrial cancer is crucial for determining treatment options and prognosis, with stages ranging from I (confined to the uterus) to IV (spread to distant organs). CA-125, a tumor marker, may be elevated in cases of endometrial cancer, although it is not specific to this malignancy. Surgical approaches often include total abdominal hysterectomy with bilateral salpingo-oophorectomy (TAH-BSO) and may be accompanied by lymphadenectomy depending on the stage of the disease.
Detailed pathology reports, imaging studies, and surgical notes are essential for accurate coding.
Diagnosis and treatment planning for endometrial cancer, management of post-operative complications.
Ensure that all relevant staging information and treatment modalities are documented to support coding.
Clear imaging reports that specify findings related to endometrial cancer.
Pre-operative imaging for staging and post-operative follow-up imaging.
Radiology reports should correlate with clinical findings and treatment plans.
Used in the surgical treatment of endometrial cancer.
Operative report detailing the procedure and findings.
Gynecologic oncology specialists should ensure comprehensive documentation of the surgical approach.
Common symptoms include abnormal uterine bleeding, pelvic pain, and changes in menstrual patterns. Patients may also experience weight loss and fatigue.
Endometrial cancer is staged based on the extent of tumor invasion, lymph node involvement, and presence of metastasis, typically classified from stage I to IV.
